Download presentation
Presentation is loading. Please wait.
Published by赫结纲 甘 Modified over 8 years ago
1
Role of Ministry of Health and Medical Education in management and control of Hepatitis C
2016/07/13
2
History of MOHME interventions-1
From 1992 HBV vaccination at birthday began in the country and till now it covers more than 99% of newborns each year about one and a half million neonates . Additionally 4 age cohorts (people born at 1988 to 1991) vaccinated , the result : All Iranian and long term residents below 29 years old are vaccinated against hepatitis B .
3
MOHME interventions -2 From the 1990s the Harm reduction efforts for HIV epidemics in the country especially in IDUs has resuled in diminishing HCV transmission . Also insuring Peg-Interferon and Ribavirin in and their availability for nearly all people , and their effect in HCV elimination in30 % of treated patients ,Both resulted in diminishing HCV transmission.
4
Incidence rate of HBV&HCV , from 2003 to 2015
5
Hepatitis C elimination program
MOHME CCDC
6
Hepatitis C elimination program
Viral hepatitis , besides AIDS and TB are important causes in morbidity and mortality due to communicable diseases globally. Elimination of epidemics of HCV until 2030 is one of the WHO goals .
7
Viral Hepatitis 90% of chronic hepatitis patients are not aware of their diseases . Each year there are 6-10 million new cases. With new drugs 90% of HCV patients cure after 3 months treatment . Number of global chronic hepatitis B&C are more than 10 times of HIV infections . .
8
Viral Hepatitis Each year 1.4 million mortality due to viral hepatitis
Now there are effective drugs for treating HCV and effective vaccine for HBV HCV elimination as a major health problem .
9
Hepatitis C elimination program
Availability of HCV lab tests from 1st(serology) to 3rd levels( molecular tests). Serology of HCV available in the periphery Creation of diagnostic and treatment algorithms for peripheral levels . Specifying routs of referral for sever and complicated cases from 1st to 3rd level .
10
Hepatitis C elimination program
Continuing neonates HBV vaccination . Vaccination of 4 more age cohorts in 4 years for coming to HBV vaccination coverage up to 35 years old Iranians . Vaccination of all prisoners(has begun) Vaccination of high risk employees like municipal workers, cemetery workers- barbers – firefighters and blood donors (has begun) .
11
HBV elimination program
High risk groups vaccination through DICs-VCTs and MMTs . Continuing HCWs , HBV vaccination .
12
HBV elimination program
Insuring Peg –interferon for treating delta hepatitis( Now insured only for HCV). Availability of Tenofovir for chronic HBV treatment ( Now available) Insuring molecular lab tests for HBV( HBV DNA- HBV viral load) that last week has been insured
13
Hepatitis C Completing insuring of new HCVtreatment drugs ( now some have been insured) Molecular HCV tests has been insured last week HCV PCR, HCV Viral Load&و HCV Genotype ،Continuing harm reduction programs especially in FSWs and IDUs.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.